Skip to content
KFF Health News KFF Health News KFF Health News KFF Health News
Donate
  • Donate
  • Connect With Us:
  • Contact
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS
  • Trump 2.0
    • Agency Watch
    • Medicaid Watch
    • State Watch
    • Rural Health Payout
  • Public Health
  • Race & Health
  • Audio
    • KFF Health News Minute
    • What the Health?
    • Health Care Helpline
    • An Arm and a Leg
    • Silence in Sikeston
    • Epidemic
  • Investigations
    • Bill Of The Month
    • Deadly Denials
    • The Body Shops
    • Broken Rehab
    • Guns, Race, and Profit
    • Dead Zone
    • Payback: Tracking Opioid Cash
    • Overpayment Outrage
    • Diagnosis: Debt
    • ALL INVESTIGATIONS
  • More Topics
    • Abortion
    • Aging
    • Climate
    • COVID-19
    • Health Care Costs
    • Insurance
    • Medicaid
    • Medicare
    • Mental Health
    • Pharma
    • Rural Health
    • Uninsured

Search Results

Filter Results

Reset filters
Date
Custom Date Range
Topic
Content Type

Showing 61-72 of 72 results for "Emily Bazar"

Sort by

Planear por adelantado para cuidados al final de la vida

By Emily Bazar July 7, 2016 KFF Health News Original

Un nuevo beneficio de salud disponible para millones de californianos anima a las personas a discutir opciones con los doctores para cuidados al final de la vida.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Advance Planning For Your End-Of-Life Care

By Emily Bazar July 7, 2016 KFF Health News Original

A new health benefit available to millions of Californians encourages people to discuss end-of-life care options with their doctors.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

How And Where To Dump Your Leftover Drugs — Responsibly

By Emily Bazar June 1, 2016 KFF Health News Original

With the nation’s opioid crisis worsening, officials want you to dispose of unwanted or expired prescription drugs. But finding a convenient take-back site requires time and patience.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Aid-In-Dying: Not So Easy

By Emily Bazar May 5, 2016 KFF Health News Original

In June, California will become the fifth state to allow terminally ill patients to end their lives with prescriptions from their doctors, but getting those prescriptions will require serious effort.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Pregnant Women Dumped By Covered California Into Medi-Cal, Without Notice Or Consent

By Emily Bazar May 3, 2016 KFF Health News Original

The problem won’t be fixed until September, though the state’s congressional delegation calls for quick action.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Warning: Government Listing Of Clinical Trials Doesn’t Disclose Costs To Patients

By Emily Bazar Photos by Heidi de Marco July 27, 2016 KFF Health News Original

Some clinics on NIH’s website charge people to participate in testing of unproven treatments — and it can come as a surprise to unsuspecting patients.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Medi-Cal se expande para los niños inmigrantes. Así es como funciona

By Emily Bazar April 12, 2016 KFF Health News Original

Entrará en vigencia una nueva ley del programa estatal de cuidado de salud de bajos ingresos para los niños en EE.UU. sin papeles.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Medi-Cal Expands To Immigrant Children. Here’s How It Works.

By Emily Bazar April 4, 2016 KFF Health News Original

New law applies state’s low-income health care program to children in the U.S. illegally.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Short-Term Health Plans: The Pros And Cons

By Emily Bazar February 1, 2016 KFF Health News Original

Columnist Emily Bazar answers a consumer’s question: “You could get one of these plans, pay the uninsured tax penalty and still pay less.”

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Want Into A Clinical Trial? Read This First.  

By Emily Bazar January 20, 2016 KFF Health News Original

Experimental drugs might help desperate patients, but don’t count on an easy cure.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Dreary Biotech Landscape Could Lead To Cheap Deals For Big Pharma

January 20, 2016 Morning Briefing

Buying smaller companies with promising drug candidates is a way for larger biopharma companies to generate growth. In other pharmaceutical news, columnist Emily Bazar explains clinical trials, and in Indiana, a state Senate committee clears a bill allowing pharmacists to diagnose customers seeking cold medicine, and deem the treatment unnecessary.

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

KFF Health News Staff

May 29, 2014 Page

Elisabeth Rosenthal, Editor-in-Chief, joined KFF Health News in September 2016 after 22 years as a correspondent with The New York Times, where she covered a variety of beats from health care to environment and did a stint in the Beijing bureau. While in China, she covered SARS, bird flu, and the emergence of HIV/AIDS in […]

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
  • Previous
  • 1
  • 2
  • 3
  • 4

More From KFF Health News

An American flag blows in the wind next to a barbed-wire fence in front of a landscape of grasslands

End of Enhanced Obamacare Subsidies Puts Tribal Health Lifeline at Risk

New Medicaid Work Rules Likely To Hit Middle-Aged Adults Hard

A box of ivermectin tablets is shown in a pharmacy.

US Cancer Institute Studying Ivermectin’s ‘Ability To Kill Cancer Cells’

A photo of a woman sitting in a chair from the shoulders down. She is taking her blood pressure.

Obamacare Sign-Ups Drop, but the Extent Won’t Be Clear for Months

KFF

© 2026 KFF. All rights reserved.

  • About Us
  • Donate
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Staff
  • Republish Our Content
  • Email Sign-Up
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS

Powered by WordPress VIP

Thank you for your interest in supporting KFF Health News, the nation’s leading nonprofit newsroom focused on health and health policy. We distribute our journalism for free and without advertising through media partners of all sizes and in communities large and small. We appreciate all forms of engagement from our readers and listeners, and welcome your support.

KHN is an editorially independent program of KFF (Kaiser Family Foundation). You can support KHN by making a contribution to KFF, a non-profit charitable organization that is not associated with Kaiser Permanente.

Click the button below to go to KFF’s donation page which will provide more information and FAQs. Thank you!

Continue